August 23, 2006
Pharmacosmos participates in the ISBT 2006 Congress
(International Society of Blood Transfusion). The ISBT 2006
Congress is held in Capetown, South Africa during the period
September 2 - 7, 2006.
For additional information about the ISBT 2006, please visit the
International Society of Blood Transfusion Website.
About Pharmacosmos A/S
Pharmacosmos develops and markets
medicines for the treatment of iron deficiency. A research-based
company, its ongoing R&D programme focuses on improving the
treatment options for healthcare professionals and patients
suffering from iron deficiency.
Pharmacosmos is a privately-owned
company and operates in more than 50 countries across Europe, the
Americas and Asia. All its manufacturing is approved by the Danish
Medicines Agency and the US Food & Drug Administration.